JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 181 | +1 | 1.42B | $361.32B | +5 | −5 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 55.10M | — | $8.03B | 0.7% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (pasif) | 29.09M | — | $4.25B | 0.6% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 24.91M | — | $3.64B | 0.4% | n/c | 1 | SEC ↗ ×2 |
| 4 | Wellington Management ✦ | 24.85M | — | $3.63B | 0.7% | n/c | 1 | SEC ↗ ×7 |
| 5 | Fisher Asset Management ✦ | 7.01M | — | $1.02B | 0.4% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 3.88M | — | $567.83M | 0.8% | n/c | 1 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 3.35M | — | $489.18M | 0.8% | n/c | 1 | SEC ↗ ×5 |
| 8 | Bridgewater Associates ✦ | 3.20M | — | $468.34M | 2.4% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 1.53M | — | $223.58M | 0.4% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.46M | — | $212.68M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 1.16M | — | $170.12M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 12 | Tweedy, Browne ✦ | 1.13M | — | $165.23M | 7.6% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.08M | — | $157.41M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 852.52K | — | $124.60M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 828.12K | — | $121.04M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 649.75K | — | $94.97M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | Markel Group ✦ | 610.80K | — | $89.27M | 0.9% | n/c | 1 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 218.02K | — | $31.87M | 0.4% | n/c | 1 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 98.36K | — | $14.38M | 0.2% | n/c | 1 | SEC ↗ |
| 20 | Fairfax Financial ✦ | 73.40K | — | $10.72M | 0.9% | n/c | 1 | SEC ↗ |
| 21 | Dodge & Cox ✦ | 21.10K | — | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 136.10K saham, $33,268 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 11.07K lbr · $3.04M
Officer · 22.53K lbr · $6.19M
Officer · 15.00K lbr · $3.95M
Officer, Director · 102.31K lbr · $26.70M
Officer, Director · 20.98K lbr · $5.50M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi
Big bank earnings arrive, with Citi, Goldman Sachs, JPMorgan Chase, and more reporting. Consumer and producer price…
Barrons